This record provides bibliographic details and links to the original research. An editorial study breakdown is not available.
Read the original research
Effects of tirzepatide on circulatory overload and end-organ damage in heart failure with preserved ejection fraction and obesity: a secondary analysis of the SUMMIT trial.
Nature medicine, 31(2), 544-551
Citation
Borlaug, Barry A; Zile, Michael R; Kramer, Christopher M; Baum, Seth J; Hurt, Karla; Litwin, Sheldon E; Murakami, Masahiro; Ou, Yang; Upadhyay, Navneet; Packer, Milton. (2025). Effects of tirzepatide on circulatory overload and end-organ damage in heart failure with preserved ejection fraction and obesity: a secondary analysis of the SUMMIT trial.. Nature medicine, 31(2), 544-551. https://doi.org/10.1038/s41591-024-03374-z